Pathogenesis of type III hyperlipoproteinemia (dysbetalipoproteinemia). Questions, quandaries, and paradoxes.
about
Variation at APOE and STH loci and Alzheimer's diseaseApolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer's diseaseEvaluation and treatment of hypertriglyceridemia: an Endocrine Society clinical practice guidelineGene therapy for lipid disordersAPOE genotype and stress response - a mini reviewApolipoprotein E: from cardiovascular disease to neurodegenerative disordersRole of apolipoprotein E in neurodegenerative diseasesLow-density lipoprotein cholesterol, apolipoprotein B, and risk of coronary heart disease: from familial hyperlipidemia to genomicsMonogenic dyslipidemias: window on determinants of plasma lipoprotein metabolismBiophysical analysis of apolipoprotein E3 variants linked with development of type III hyperlipoproteinemiaPostprandial changes in high density lipoproteins in rats subjected to gavage administration of virgin olive oilThe D9N, N291S and S447X variants in the lipoprotein lipase (LPL) gene are not associated with Type III hyperlipidemia.Treatment options for hypertriglyceridemia: from risk reduction to pancreatitis.Influence of domain stability on the properties of human apolipoprotein E3 and E4 and mouse apolipoprotein E.Apolipoprotein E - A Multifunctional Protein with Implications in Various Pathologies as a Result of Its Structural FeaturesThe potential applications of Apolipoprotein E in personalized medicineHuman plasma lipid modulation in schistosomiasis mansoni depends on apolipoprotein E polymorphismEffect of apolipoprotein E genotype on apolipoprotein B-100 metabolism in normolipidemic and hyperlipidemic subjectsMacrophage-derived apoESendai suppresses atherosclerosis while causing lipoprotein glomerulopathy in hyperlipidemic mice.Impaired LDL receptor-related protein 1 translocation correlates with improved dyslipidemia and atherosclerosis in apoE-deficient mice.The expression of type III hyperlipoproteinemia: involvement of lipolysis genesVery-Low-Density Lipoprotein-Associated Apolipoproteins Predict Cardiovascular Events and Are Lowered by Inhibition of APOC-III.Genetics of Alzheimer diseaseApolipoprotein E: structure and function in lipid metabolism, neurobiology, and Alzheimer's diseases.Function and comorbidities of apolipoprotein e in Alzheimer's disease.The influence of intense intermittent versus moderate continuous exercise on postprandial lipemiaApoE polymorphism may determine low-density lipoprotein cholesterol level in association with obesity and metabolic syndrome in postmenopausal Korean womenCase series of type III hyperlipoproteinemia in children.Acrolein modification impairs key functional features of rat apolipoprotein E: identification of modified sites by mass spectrometry.Syndecan-1 mediates internalization of apoE-VLDL through a low density lipoprotein receptor-related protein (LRP)-independent, non-clathrin-mediated pathwayDysbetalipoproteinemia: Two cases report and a diagnostic algorithmDiagnosis and management of chronic pancreatitisHigh density lipoprotein structure-function and role in reverse cholesterol transport.Targeted In Situ Gene Correction of Dysfunctional APOE Alleles to Produce Atheroprotective Plasma ApoE3 Protein.2-Aminopurine inhibits lipid accumulation induced by apolipoprotein E-deficient lipoprotein in macrophages: potential role of eukaryotic initiation factor-2alpha phosphorylation in foam cell formation.Clinical and molecular characterization of a severe form of partial lipodystrophy expanding the phenotype of PPARγ deficiency.Influence of Abdominal Obesity on the Lipid-Lipoprotein Profile in Apoprotein E2/4 Carriers: The Effect of an Apparent Duality.Cerebrospinal fluid APOE levels: an endophenotype for genetic studies for Alzheimer's diseaseApolipoprotein E isoform-specific binding to the low-density lipoprotein receptor.Apolipoprotein E gene is related to mortality only in normal weight individuals: the Rotterdam Study
P2860
Q21203895-33049E20-ECF4-4D23-B29C-D8B4A91F07F3Q22248091-6CA40DBE-0DBF-48E1-8845-C4634DAAEF28Q24608464-71D9F4DB-AE33-4C1A-953F-691D7BC02B45Q24792755-1FFB39C4-0637-4460-A34C-4E7AC81F2A39Q26741633-F2F037CD-35F9-4757-9E0F-4C222957548DQ26747482-A15D13C2-0AC5-4228-B350-A48D4BD23928Q26799413-674FBE4D-E4C0-4FFD-89C9-DFC2185740AFQ26853114-E541EAF8-8058-4D19-934E-EFA443DA07C8Q28363810-4A855A3C-AE19-4AEF-A84B-3C51CF285605Q28477741-7C5C4E66-86B3-4211-B9CA-F0B2AAA7C193Q28569962-8D1813D2-C1BB-4B4F-834E-4348D250655EQ33295440-9CD48223-25FA-47B5-B1BD-F8EE272B93DBQ33639909-4BB99242-A49A-4837-AFF5-1A384EB52833Q33807188-63577178-966E-48E6-8377-04307C1E00BDQ33813945-31D02B74-44C3-4856-8D15-426DB9AD795CQ33858831-0FE47626-B050-490B-B71A-9B983B012EBEQ33933106-0CB05958-54B0-40BC-9F69-A9A2F916BDFBQ33993136-1EF22E66-E748-4EBB-BFDB-227A864A1313Q34238672-83E7BF2D-EAE0-40D6-B566-4722E950BAFAQ34305393-159935B5-40CA-465A-A68D-9284E3289168Q34326186-285034C6-6CCA-42CF-AE25-8F98C6187978Q34551430-590564DE-8E5F-4B70-B97D-B124DF37B04AQ34604101-309AB977-9EE0-4473-AFFE-41534360FE9DQ34621541-ED47E786-540C-4857-9323-BA9192AF0243Q34951817-E630A418-FC55-479F-8F2B-9799F12CFF40Q34978714-79159726-B5EF-42D5-9C55-5AF94C430313Q35003338-7F566B23-0D95-45B8-B7DF-AF73F623C2B8Q35048704-211ABA77-3408-46CC-87D5-292F49877390Q35064519-493E8D5D-FFDE-4E67-B3A3-CDE4C6FC92B0Q35070156-DD4F2461-7EA6-4AD7-8358-88EBC062DAF7Q35335896-29C30B13-5669-4859-BDC9-91DFB24A1D3FQ35522501-138B6DDE-4AE7-43FA-87C8-9073D75CBFB7Q35547011-DEFA7B23-E8D6-47A9-BDF4-7C687C85C745Q35974993-82456751-EC28-4121-A518-436480F3DC85Q36060341-DDC8136E-50FB-4C9C-96AA-DC047DCFBC68Q36145262-D717E3C8-8A7C-4A7B-8E24-A098E9866328Q36269808-B07B8678-AE8F-4A62-8187-717CF4DBBB6BQ36283394-0264CEA4-3B94-419A-AC2F-EDA1E8E0FA26Q36327871-ED56523B-A963-45A1-A114-3328CB566C4EQ36428621-D4481DEB-F289-4840-B620-108CCF6AEB27
P2860
Pathogenesis of type III hyperlipoproteinemia (dysbetalipoproteinemia). Questions, quandaries, and paradoxes.
description
1999 nî lūn-bûn
@nan
1999 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Pathogenesis of type III hyper ...... ns, quandaries, and paradoxes.
@ast
Pathogenesis of type III hyper ...... ns, quandaries, and paradoxes.
@en
type
label
Pathogenesis of type III hyper ...... ns, quandaries, and paradoxes.
@ast
Pathogenesis of type III hyper ...... ns, quandaries, and paradoxes.
@en
prefLabel
Pathogenesis of type III hyper ...... ns, quandaries, and paradoxes.
@ast
Pathogenesis of type III hyper ...... ns, quandaries, and paradoxes.
@en
P2093
P1476
Pathogenesis of type III hyper ...... ons, quandaries, and paradoxes
@en
P2093
P304
P577
1999-11-01T00:00:00Z